GlaxoSmithKline Biologicals s.a.:

Please note that March 21, 2022, CFDI sent the Notification of Drug Remote Inspection Results of Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae) to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon as possible.

Contact: Ping Zhang

Tel.+86 10 68441691

Center for Food and Drug Inspection of NMPA

 March 21, 2022